| 18F-FDG | 18F-Flurodeoxyglucose |
| ACE-I | Angiotensin-converting enzyme |
| Ang-II | Angiotensin-II |
| APC/C | Complex/Cyclosome |
| AS | aortic stenosis |
| AV | Aortic valve |
| BMP-2 | Bone morphogenetic protein-2 |
| C/EBPβ | CCAAT/enhancing-binding protein |
| CACNA1C | Calcium voltage-gated channel subunit alpha 1 C |
| CAVD | Calcific aortic valve disease |
| CAVS | Calcific aortic valve stenosis |
| CBP | CREB-binding protein |
| CCL19 | C-C motif chemokine ligand 19 |
| CD11 | Surface marker of M1 |
| CLPP | Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit |
| CROT | Carnitine O-octanoyltransferase |
| CTB | Cytotrophoblast |
| CVD | Cardiovascular disease |
| DRP1 | Dynamin-related protein 1 |
| ECM | Extracellular matrix |
| EPAS-1 | Endothelial PAS domain protein-1 |
| EPO | Erythropoietin |
| ERK1/2 | Extracellular signal-regulated kinase |
| FAT/CD36 | Fatty acid translocase |
| FOURIER | Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk |
| Glut 1, 4 | Glucose transporter 1 and 4 |
| HAVEC | Human aortic endothelial cells |
| HC-OA | Human osteoarthritic |
| HF | Heart failure |
| HIF-1α | Hypoxia-inducible factor 1 alpha subunit |
| HIFs | Hypoxia-inducible transcription factors |
| HMOX1 | Heme Oxygenase 1 |
| HTRA2 | HtrA Serine Peptidase 2 |
| HUVEC | Human umbilical endothelial cells |
| ICAM-1 | Intracellular adhesion molecule-1 |
| IFN-γ | Interferon-γ |
| IHD | ischemic heart disease |
| IL- | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| LDH-A | Lactate dehydrogenase-A |
| LDL | Low-density lipoprotein |
| Lp(a) | Lipoprotein a |
| LV | Left ventricular |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MMP9 | Matrix metalloproteinase 9 expression |
| MMPs | Matrix metalloproteinases |
| MMP-9i | Matrix metalloproteinase 9 inhibitor |
| MT1 | Melatonin receptor |
| mtDNA | Mitochondrial DNA |
| mtROS | Mitochondrial ROS |
| mtUPR | Mitochondrial unfolded protein response |
| N-acetyl-5-methoxytryptamine | Melatonine |
| NF-κB | Nuclear factor kappa B |
| NLRC4 | Pyrin domain-containing protein |
| NOS | Nitric oxide synthase |
| O2 | Oxygen |
| OPA1 | Optic atrophy 1 |
| OXPHOS | Oxidative phosphorylation |
| PAV | Porcine AV |
| PCSK9 | Proprotein convertase subtilisin/kexin type 9 |
| PDK | Dehydrogenase kinase isoform 1 |
| PET | Positron emission tomography |
| PGK1 | Phosphoglycerate kinase-1 |
| PHD1, -2, -3 | Propyl-hydroxylase-1, -2, and -3 enzyme activity |
| PI3K/Akt | P hosphatidylinositol 3-kinase (PI3K)-Akt (protein kinase B) |
| PKM2 | M2 isoform of pyruvate kinase |
| PTP1B | Protein tyrosine phosphatase 1B |
| pVHL | von Hippel–Lindau |
| RANKL | Receptor-activator of nuclear factor κB ligand |
| SCG2 | Secretogranin II |
| sFlt1 | Soluble fms-like tyrosine kinase 1 |
| SMC | Smooth muscle cells |
| SOD2 | Superoxide dismutase 2 |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| TG | Triglyceride levels |
| TGF-β | Transforming growth factor-beta |
| TLR | Toll-like receptor |
| UBE2C | Ubiquitin E2 ligase C |
| VECs | Valvular endothelial cells |
| VEGF | Vascular endothelial growth factor |
| VICs | valvular interstitial cells |
| VSMC | Vascular smooth muscle cells |
| XPO1 | Exportin-1 |